MT-II’s structure and strong binding to MC4R receptors make it a “superpotent” melanocortin agent compared to natural peptides like α-MSH. It can cross the blood-brain barrier, which allows it to influence functions beyond pigmentation, notably inducing erections through central nervous mechanisms. In animal studies, MT-II administration caused dose-dependent erections in rats through intracerebral, intrathecal, and intravenous routes. These findings pointed to MT-II’s central proerectile action rather than peripheral effects, establishing it as a promising agent for treating erectile dysfunction by acting on the central nervous system rather than direct blood flow regulation.
King, S.H., Mayorov, A.V., Balse-Srinivasan, P., Hruby, V.J., Vanderah, T.W., and Wessells, H. (2007). Melanocortin receptors, melanotropic peptides and penile erection. Current Topics in Medicinal Chemistry.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about MT II by Baboon Pharma, consult with your doctor or healthcare professional.
King, S.H., Mayorov, A.V., Balse-Srinivasan, P., Hruby, V.J., Vanderah, T.W., and Wessells, H. (2007). Melanocortin receptors, melanotropic peptides and penile erection. Current Topics in Medicinal Chemistry.
King, S.H., Mayorov, A.V., Balse-Srinivasan, P., Hruby, V.J., Vanderah, T.W., and Wessells, H. (2007). Melanocortin receptors, melanotropic peptides and penile erection. Current Topics in Medicinal Chemistry.
King, S.H., Mayorov, A.V., Balse-Srinivasan, P., Hruby, V.J., Vanderah, T.W., and Wessells, H. (2007). Melanocortin receptors, melanotropic peptides and penile erection. Current Topics in Medicinal Chemistry.